Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves.
about
Involvement of Immune Cell Network in Aortic Valve Stenosis: Communication between Valvular Interstitial Cells and Immune CellsCathepsin G activity lowers plasma LDL and reduces atherosclerosisCalcific aortic valve stenosis: methods, models, and mechanismsACE inhibition attenuates uremia-induced aortic valve thickening in a novel mouse model.An emerging role of mast cells in cerebral ischemia and hemorrhage.Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage.Protein targets of inflammatory serine proteases and cardiovascular disease.Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations.Cathepsin G deficiency reduces periaortic calcium chloride injury-induced abdominal aortic aneurysms in mice.Inflammatory regulation of valvular remodeling: the good(?), the bad, and the ugly.Pathogenesis of aortic stenosis: not just a matter of wear and tearDifferent roles of mast cells in obesity and diabetes: lessons from experimental animals and humans.Prevalence of valvular heart diseases and associated risk factors in Han, Uygur and Kazak population in Xinjiang, China.Mast cells in human stenotic aortic valves are associated with the severity of stenosisMast cells in vulnerable atherosclerotic plaques--a view to a kill.Prevalence and correlates of valvular heart diseases in the elderly population in Hubei, ChinaSmooth Muscle Cell Foam Cell Formation, Apolipoproteins, and ABCA1 in Intracranial Aneurysms: Implications for Lipid Accumulation as a Promoter of Aneurysm Wall Rupture.Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseases.Mast cells: pivotal players in cardiovascular diseases.Pathophysiologic mechanisms of calcific aortic stenosis.Aortic valvular heart disease: Is there a place for angiotensin-converting-enzyme inhibitors?Aortic valve stenosis and arterial hypertension: a synopsis in 2013.Cells and extracellular matrix interplay in cardiac valve disease: because age matters.Targeting vasoactive peptides for managing calcific aortic valve disease.Pathophysiology of Aortic Stenosis and Mitral Regurgitation.Discriminating between the activities of human cathepsin G and chymase using fluorogenic substrates.Management of atherosclerosis with antiallergic medicine: a lesson from the mouse model.Lowering plasma cholesterol levels halts progression of aortic valve disease in mice.Accumulation of cholesterol precursors and plant sterols in human stenotic aortic valves.Mast Cells: Key Contributors to Cardiac Fibrosis.Systolic hypertension and progression of aortic valve calcification in patients with aortic stenosis: results from the PROGRESSA study.Impaired fibrinolysis is associated with the severity of aortic stenosis in humans.
P2860
Q26764864-81B47BD5-1B41-4BF5-98FE-45DB411ECBDBQ28245234-4471A676-8E55-4EAE-AE00-589F1BE23258Q30503246-24434C24-5DD6-42D8-A083-9DF2CF13B2F9Q33414426-20266721-4670-4459-ACD7-FAF65BE4C68BQ33438542-52136DD4-4811-49AD-8B5E-A7527799BF2DQ34093771-7BDF9E10-23CC-4D25-A57F-D673858A65D9Q34114355-923CF20A-B6F4-4BDA-8C05-B81C1B108AC4Q34583579-4D4D8FBD-F248-4D05-84A7-F891206E0F98Q34978499-8BF68143-F756-453B-9C97-92A6EC816961Q35116249-AE4A9665-9B8F-4B75-82D0-8E3ED251AF38Q35660101-B097B707-F95B-40F5-885F-84FEB967EE24Q35927429-C6C5DAA4-C8BD-4509-8B95-EC25915850E1Q36326942-871BFABE-D54C-42F4-862E-5F216373E522Q36665953-FC6C465F-EA4C-4774-A391-A6A9BF3F1FA2Q36924398-9444C2DA-F741-44C1-88AA-5607ABCF0BB7Q36959326-08D97A7E-C07E-4E3D-A816-E104913EBA47Q37019739-78C13FED-FBF7-4C1D-A18C-2E90F89D7943Q37578873-9FD90C87-BF8E-4506-86B5-6B008A9506FBQ37638250-70133C8F-7490-414B-879E-FB767B93A948Q37987807-46CDE53B-BB4C-4A96-9371-ED6F915F55A3Q38069196-D5AFE227-1CEB-41EE-80A4-FB5EEEAD6D9AQ38120708-1C6723D9-CC9F-4257-8440-7180EA9047D6Q38718100-790D31BB-A93D-45ED-BA78-57608497645FQ38943935-6AA31DE0-D5BD-429A-A1C5-290267A68CA3Q39390979-A20B58E6-A21E-4038-A5D4-CABB6B1EFE46Q39539160-C5F3266E-0886-43DD-A437-77B4B0DB1E6EQ40159308-681EC800-C071-4E77-BAC9-2CB1FDB9161DQ41946374-3BA2E9EA-F6C1-4AD1-8DDD-4BCB70C9A478Q46656595-F8BDC149-EE40-4A2B-80B0-D73C7826F7BCQ48253413-3E5A6256-2DEB-4B0B-A708-7EA6BE94B19FQ49215602-D9026D42-B0D5-47BC-A7F6-D014047AD930Q51283131-7176FB15-94CD-47FE-A9CE-F3982A21FD37
P2860
Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Possible role for mast cell-de ...... ing of stenotic aortic valves.
@en
Possible role for mast cell-de ...... ing of stenotic aortic valves.
@nl
type
label
Possible role for mast cell-de ...... ing of stenotic aortic valves.
@en
Possible role for mast cell-de ...... ing of stenotic aortic valves.
@nl
prefLabel
Possible role for mast cell-de ...... ing of stenotic aortic valves.
@en
Possible role for mast cell-de ...... ing of stenotic aortic valves.
@nl
P2093
P2860
P356
P1476
Possible role for mast cell-de ...... ling of stenotic aortic valves
@en
P2093
Heikki Turto
Jani Lappalainen
Jyri Lommi
Kalervo Werkkala
Ken A Lindstedt
Markku Kupari
Mika Laine
Petri T Kovanen
Satu Helske
P2860
P304
P356
10.1093/EURHEARTJ/EHI706
P577
2006-01-09T00:00:00Z